Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$1.49B |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$423M |
| 3 |
SLB Ltd
SLB
|
+$408M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$340M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
451
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.69M | ﹤0.01% |
393,266
-7,249
| -2% | -$46K |
|
452
Quanex
NX
$883M
| $2.65M | ﹤0.01% |
152,132
+1,999
| +1% | +$38.9K |
|
453
Nike
NKE
$63.3B
| $2.63M | ﹤0.01% |
39,559
-139
| -0.4% | -$9.17K |
|
454
iShares Global Healthcare ETF
IXJ
$4.08B
| $2.59M | ﹤0.01% |
46,444
-681,418
| -94% | -$39.2M |
|
|
ARRY
455
DELISTED
Array Biopharma Inc
ARRY
| $2.58M | ﹤0.01% |
158,223
-3,210
| -2% | -$51.4K |
|
|
CLVS
456
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.53M | ﹤0.01% |
47,961
| – | – |
|
|
CSFL
457
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $2.47M | ﹤0.01% |
93,257
+1,399
| +2% | +$37.5K |
|
458
Icon
ICLR
$12.2B
| $2.47M | ﹤0.01% |
20,916
-4,200
| -17% | -$482K |
|
|
ICPT
459
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.45M | ﹤0.01% |
39,752
-100
| -0.3% | -$6.03K |
|
|
LMNX
460
DELISTED
Luminex Corp
LMNX
| $2.36M | ﹤0.01% |
111,939
+246
| +0.2% | +$5.03K |
|
|
PRAH
461
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.35M | ﹤0.01% |
28,380
-5,170
| -15% | -$459K |
|
462
PNC Financial Services
PNC
$100B
| $2.33M | ﹤0.01% |
15,382
-7,618
| -33% | -$1.18M |
|
463
Southside Bancshares
SBSI
$972M
| $2.28M | ﹤0.01% |
65,707
-691
| -1% | -$24K |
|
|
PGNX
464
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.27M | ﹤0.01% |
303,692
| – | – |
|
465
CF Industries
CF
$18.2B
| $2.25M | ﹤0.01% |
59,727
-2,429
| -4% | -$98.9K |
|
466
Knowles
KN
$3.2B
| $2.24M | ﹤0.01% |
177,698
-12,025
| -6% | -$175K |
|
|
MNTA
467
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.21M | ﹤0.01% |
121,507
-3,000
| -2% | -$50K |
|
468
Booking.com
BKNG
$149B
| $2.15M | ﹤0.01% |
25,850
-1,600
| -6% | -$126K |
|
469
Petrobras Class A
PBR.A
$109B
| $2.13M | ﹤0.01% |
164,202
| – | – |
|
470
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.96B
| $2.04M | ﹤0.01% |
79,676
-2,028
| -2% | -$52K |
|
471
Travere Therapeutics
TVTX
$5.11B
| $1.97M | ﹤0.01% |
87,905
| – | – |
|
472
VanEck Vietnam ETF
VNM
$506M
| $1.96M | ﹤0.01% |
100,100
| – | – |
|
473
Lantheus
LNTH
$6.59B
| $1.91M | ﹤0.01% |
119,793
+1,820
| +2% | +$35.5K |
|
474
B&G Foods
BGS
$290M
| $1.88M | ﹤0.01% |
79,119
+1,465
| +2% | +$44.8K |
|
475
Entravision Communication
EVC
$1.02B
| $1.86M | ﹤0.01% |
394,803
+7,551
| +2% | +$48.8K |
|
Similar funds
Fisher Asset Management's Q1 2018 Portfolio in Review
As of Q1 2018, Fisher Asset Management held 991 positions worth $75.4B, down 1.5% from $76.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Fisher Asset Management's Q1 2018 filing shows 69 new, 261 increased, 401 reduced and 162 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B. The largest sale was Barclays ETN+ FI Enhanced Global High Yield ETN, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Fisher Asset Management's largest Q1 2018 buy was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B.
- Fisher Asset Management added most to SLB Ltd in Q1 2018, an estimated $408M increase.
- Fisher Asset Management's biggest Q1 2018 reduction was Barclays ETN+ FI Enhanced Global High Yield ETN, cutting an estimated $1.59B.
- Fisher Asset Management fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $123M.
- Fisher Asset Management's ten largest holdings make up 26% of its $75.4B portfolio in Q1 2018.
- Fisher Asset Management opened 69 new positions and closed 162 in Q1 2018.
- Fisher Asset Management's portfolio value fell 1.5% quarter-over-quarter to $75.4B.
Based on Fisher Asset Management's 13F filing for Q1 2018, filed 19 Apr 2018.